Posted in | News | Chemistry | Precious Metal

Sigma Aldrich Launch Novel Compound Handling Technology

Sigma-Aldrich is pleased to launch ChemDose(TM), a novel compound handling technology designed to enable easy delivery of reagents and catalysts in tablet form.

ChemDose, co-developed with Reaxa, Ltd., involves absorption of reagents into an inert tablet matrix. On exposure to solvents, the reagents readily dissolve out, leaving behind an easily removed insoluble tablet. ChemDose tablets offer the timesaving convenience of pre-weighed reagents, minimize waste, and are compatible with microwaves, parallel synthesis equipment, non-aqueous and aqueous solvents. Reaction kinetics utilizing ChemDose closely parallel the corresponding conventional reagent under the same conditions. Additionally, ChemDose tablets minimize exposure and offer convenient handling of difficult-to-use chemicals.

"ChemDose is another way to accelerate the success of our customers, and we look forward to expanding the ChemDose offering through customer feedback," said Charles Davis, Technology Transfer Manager, Chemistry, Sigma-Aldrich.

Currently available ChemDose products include common palladium catalysts, ligands for cross-coupling, and peptide coupling reagents.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sigma-Aldrich. (2019, March 01). Sigma Aldrich Launch Novel Compound Handling Technology. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=8942.

  • MLA

    Sigma-Aldrich. "Sigma Aldrich Launch Novel Compound Handling Technology". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=8942>.

  • Chicago

    Sigma-Aldrich. "Sigma Aldrich Launch Novel Compound Handling Technology". AZoM. https://www.azom.com/news.aspx?newsID=8942. (accessed November 21, 2024).

  • Harvard

    Sigma-Aldrich. 2019. Sigma Aldrich Launch Novel Compound Handling Technology. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=8942.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.